A synergistic effect of therapy using nanoparticles containing a STING pathway agonist (cGAMP) with mannose alongside anti-PD-L1 antibodies was shown by Li et al. The combination therapy showed a significantly better anti-tumor effect in melanoma treatment than each drug used alone, highlighting the potential of this strategy [55]. The gene discussed is STING1; the disease is melanoma.